Samsung Electronics Co., Ltd.

Hanmi Pharm. Co., Ltd.

Korea Electrotechnology Research Institute

Hanmi Science Co., Ltd.

Hynix Semiconductor Inc.

Hyundai Electronics Industries Co. Ltd.

Samsung Display Co., Ltd.

Skhynix Inc.

Lg Cable Ltd.

Lg Innotek Co., Ltd.

Sungkyunkwan University

Soongsil University

University of Seoul Industry Cooperation Foundation

Enf Technology Co., Ltd.

Hanmi Holdings Co., Ltd.

Young Jin Park

Se Chang Kwon

Sung Youb Jung

Hyun Soo Park

Jong Hyun Shin

Kwan Ho Kim

Chang Ki Lim

In Woo Jang

Kye Nam Lee

Chang Shuk Kim

Jae Hwi Jang

Jong Suk Lee

Jin Wook Kim

Hee Bok Kang

In Young Choi

Sung Min Bae

Myung Hyun Jang

Young Kyung Park

Dae Hae Song

Euh Lim Oh

Jung Kuk Kim

Jae Hyoung Lim

Dong Yun Jeong

Ling Ai Shen

Seaung Suk Lee

Soon Woo Lee

Ji Myung Kang

Gwan Sun Lee

Jae Hyuk Choi

Jong Choul Kim

Jae Wan Hong

Dae Seong Im

Yong Ku Baek

Sung Mok Seo

Jong Ryul Yang

Sung H Hong

Jin Sung Kim

Jong Soo Lee

Dong Sung Kim

Dae Jin Kim

Tae Hyung Hwang

Jae Won Choi

Won Ho Kim

Sang H Woo

Sung Chul Shin

Jin Sun Kim

Yong Sik Yu

Seong Su Lim

Jae Hee Shin

Ki-Doo Choi

Won Lee

Jong Min Shin

Ha E Jeon

Kyoung Hun Han

Han Soo Jeon

Hee Kyung

Sung Ho Cho

Sung Jin Kim

Hyuk Kang

Jun Ho Song

Jin Young Lee

Yeo Geon Yoon

Jae Hak Lee

Kyoung Hoon Kim

Hong Sick Park

Seung Hyun Park

Ki Min Lee

Young Je Cho

Dong Jae Shin

Sung In Ro

Ock Soo Son

Min Young Kim

Kyu Suk Lee

Yo An Shin

Chan Ik Park

Jae Woo Jeong

Seung Ho Yoon

Jong Ju Park

Bong Kyun Kim

Hyung Sup Jung

Young Eun Woo

Jong Wu Baek

In Hyung Jung

Woong Ki Jeon

E Rang Lim

Seung Jin Yeom

Hyun Ju Kim

Sang Yul Baik

Won Cheol Lee

Seon Ah Cho

Zhong Lu

Hyung Min Chang

Won Chul Ju

Dong Rak Shin

Do Hyun Kim

Hyo Won Park

Sang Moon Yun

Dong Taek Lee

Jae Hee Hee Shin

Joong Sun Won

The present invention relates to a WPT coil and an apparatus having same, and more particularly, to a WPT coil configured to have a three-dimensional shape by using a flexible substrate or the like, and an apparatus having same. A WPT coil is provided in a WPT device to transmit or receive wireless power, according to the present invention, the WPT coil comprising: a flexible substrate; and a coil structure provided on the flexible substrate, wherein the WPT coil forms a three-dimensional shape rather than a flat plate shape.

Three-dimensional wireless power transfer coil and apparatus having same

A high performance packet stream storage method. Original packet data from data traffic transmitted over a network is collected. Collected original packet data is written in a memory. Metadata from the collected original package data is extracted and metadata is written in the memory. The original packet data and the metadata is stored in a storage unit.

Network forensic system and method

The present invention relates to a novel peptide of a glucagon derivative and a composition for preventing or treating obesity comprising the peptide as an active ingredient. The glucagon derivative according to the present invention shows a more excellent activating effect with regard to both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon, and thus can be widely used as an effective agent for treating obesity.

Glucagon derivatives

The present invention relates to an insulin analog conjugate and use thereof.

Insulin analog complex with reduced affinity for insulin receptor and use thereof

A glucagon derivative, a long-acting conjugate of the glucagon derivative, and a use thereof are disclosed.

Glucagon derivative and a composition comprising a long acting conjugate of the same

Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex prepared by the present invention may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.

Protein complex by use of a specific site of an immunoglobulin fragment for linkage

A a triple agonist having activities to all of glucagon, GLP-1, and GIP receptors is disclosed. Uses of the triple agonist are disclosed.

Triple glucagon/GLP-1/GIP receptor agonist

Provided is a complex composition, of which positional isomers are minimized by using a N-terminus of an immunoglobulin Fc region as a binding site when the immunoglobulin Fc region is used as a carrier. Also provided are a protein complex which is prepared by N-terminal-specific binding of immunoglobulin Fc region, thereby prolonging blood half-life of the physiologically active polypeptide, maintaining in vivo potency at a high level, and having no risk of immune responses, a preparation method thereof, and a pharmaceutical composition including the same for improving in vivo duration and stability of the physiologically active polypeptide. The protein complex may be usefully applied to the development of long-acting formulations of various physiologically active polypeptide drugs.

The present invention relates to a glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof, and in particular, for metabolic syndrome, hypoglycemia, and congenital hyperinsulinism.

Glucagon derivative, conjugate thereof, composition comprising same, and therapeutic use thereof

A long-acting conjugate of a triple agonist which has activities to all of glucagon, GLP-1, and GIP receptors and uses thereof.

Long-acting conjugate of triple glucagon/GLP-1/GIP receptor agonist

An insulin conjugate having improved in vivo duration and stability is provided. The conjugate is prepared by covalently linking insulin with an immunoglobulin Fc region via a non-peptidyl polymer, a long-acting formulation comprising the same, and a preparation method thereof. The insulin conjugate of the present invention maintains in vivo activity of the peptide at a relatively high level and remarkably increases the serum half-life thereof, thereby greatly improving drug compliance upon insulin treatment.

Insulin conjugate using an immunoglobulin fragment

Growing community of inventors

Hwaseong-si, South Korea

Young Jin Park